Clinical Trial Metrics

Global Clinical Trials Intelligence Dashboard

Real-time Monitoring of Operational Performance & Scientific Integrity Across Trial Lifecycles

Real-time tracking of studies, interventions, and sponsor performance.

Track 35-month average durations and 510,023 primary completions.

Analyze age/gender distributions from eligibility.

Monitor 40.4% drug, 20.4% biologic, and 18.4% procedural trials.

Benchmark National Cancer Institute, AstraZeneca, and 12K+ sponsors.

Compare site activation speeds across countries.

Flag 13% active trials with attrition risks.

Track trials performance across recruitment, retention and study compliance.

Powered by Nakunj Inc.